DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Upcoming Events
  • Glioblastoma, Prostate cancer, Squamous Cell Carcinoma of the Head and Neck | Access and Reimbursement | US

    The success of an anticancer therapy is not only dependent on the outcome of its pivotal trial, but also on that trial’s design, which is examined by the regulatory bodies, payers, and prescribers....

    Sep 07
  • Multiple Sclerosis: Current Treatment in the EU5

    The EU5 market for multiple sclerosis (MS) disease-modifying therapies (DMTs) is dynamic and evolving. Several MS DMTs have launched in the past five years, and new entrants are on the horizon....

    Sep 08
  • Human Immunodeficiency Virus | Access and Reimbursement | US

    This webinar outlines the market access factors that influence the success of HIV antiretroviral therapies in the U.S. market. The webinar will focus on research that explores physician and payer...

    Sep 14
  • ARIA Resort & Casino

    Oncology Account Management Training

    Filed under: Public Training

    Registration, Agenda, and Brochure coming soon!

    Sep 20-22
  • Eylea and Ozurdex treatment dynamics in DME

    Following expanded labeling for DME in Europe in 2014, ophthalmologists gained additional treatment options with Bayer’s Eylea and Allergan’s Ozurdex. In this webinar, we explore how physicians...

    Sep 21
  • Insights into the Current Treatment Landscape for the Hospital-Treated Gram-Negative Infections Market in Europe

    Antimicrobial resistance has forced physicians to increase prescribing of powerful later-line antibiotics. As a result, an urgent need and commercial opportunities exist for therapies demonstrating...

    Sep 27

    Digital Pharma East

    Filed under: Industry Event - Speaking

    The conference will cover areas like the industry leaders, analysts and business strategists will also explore new possibilities in the research and marketing of pharmaceutical products. Booth...

    Oct 24-27
  • Austria Center Vienna

    ISPOR European Congress

    Filed under: Industry Event - Exhibiting

    Managing Access to Medical Innovation: Strengthening the Methodology-Policy Nexus

    ISPOR is recognized globally as the leading educational and scientific organization for health economics and outcomes research (HEOR) and its use in health care decisions. Booth Location: TBD

    Oct-Nov 29-02
  • Germany

    Bio Europe Fall

    Filed under: Industry Event - Exhibiting

    BIO-Europe® is Europe's largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the...

    Nov 07-09
  • The Charles Hotel, Cambridge MA

    Harvard Business School Healthcare Alumni Conference

    Filed under: Industry Event - Speaking

    Healthcare is a dynamic industry, where new technologies, providers, regulations, and trends continually join the marketplace. One thing remains constant – the need to be connected to people,...

    Nov 10-11
1-10 of 11